Discover

MXCT
MaxCyte, Inc.
1.24
16 x 1.24
7 x 1.25
bid
ask
+
0.03
2.48%
11 @ 04:00 PM
1.26 +0.02 (1.54%)
Ytd-20.00%
1y-6.06%
1.20
day range
1.26
0.64
52 week range
1.86
Open1.22Prev Close1.21Low1.20High1.26Mkt Cap132.83M
Vol0.00Avg Vol1.27MEPS-0.34P/E-3.65Forward P/E-10.41
Beta1.16Short Ratio4.08Inst. Own70.20%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg1.19200-d Avg1.151yr Est8.67

MXCT News

benzinga.com
MaxCyte Enters Into Technology License Partnership With Genentech To Support Development Of Cell The

MaxCyte, Inc. (NASDAQ:MXCT), a leading cell-engineering company providing enabling platform technolo

MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
globenewswire.com
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell The

ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engin

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
globenewswire.com
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m

VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering
businesswire.com
VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering

ROCKVILLE, Md. & CHICAGO--(BUSINESS WIRE)-- #BioTechNews--VectorBuilder, a global leader in gene del

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript
seekingalpha.com
MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript

MaxCyte Q1 Earnings Call Highlights
marketbeat.com
MaxCyte Q1 Earnings Call Highlights

MaxCyte NASDAQ: MXCT reported lower first-quarter revenue compared with the prior year, as managemen

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Es

MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance
globenewswire.com
MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance

First quarter 2026 total revenue of $9.7 million, including $6.2 million of core revenue and $3.4 mi

Earnings Scheduled For May 12, 2026
benzinga.com
Earnings Scheduled For May 12, 2026

MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026
globenewswire.com
MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026

ROCKVILLE, Md., April 29, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-en

MaxCyte, Inc. (NASDAQ:MXCT) Receives $5.50 Average Price Target from Analysts
defenseworld.net
MaxCyte, Inc. (NASDAQ:MXCT) Receives $5.50 Average Price Target from Analysts

MaxCyte, Inc. (NASDAQ: MXCT - Get Free Report) has been assigned a consensus rating of "Hold" from t

MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ROCKVILLE, Md., March 31, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engi

MaxCyte Q4 Earnings Call Highlights
defenseworld.net
MaxCyte Q4 Earnings Call Highlights

MaxCyte (NASDAQ: MXCT) executives told investors the company made "meaningful progress" in 2025 desp

MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript
seekingalpha.com
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates
zacks.com
MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates

MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Es

MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
globenewswire.com
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guid

Fourth quarter 2025 total revenue of $7.3 million at the top of the range of previous preliminary an

Earnings Scheduled For March 24, 2026
benzinga.com
Earnings Scheduled For March 24, 2026

MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
globenewswire.com
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer

ROCKVILLE, Md., March 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engi

MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
globenewswire.com
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery

ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
globenewswire.com
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leadi

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
businesswire.com
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufac

MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript
seekingalpha.com
MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript

MaxCyte, Inc. ( MXCT ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Mahe

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025

Earnings Scheduled For November 5, 2025
benzinga.com
Earnings Scheduled For November 5, 2025

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
benzinga.com
This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com
Earnings Scheduled For August 6, 2025

benzinga.com
Earnings Scheduled For May 7, 2025

benzinga.com
Earnings Scheduled For March 11, 2025

benzinga.com
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-

benzinga.com
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And O

benzinga.com
Earnings Scheduled For March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

benzinga.com
Earnings Scheduled For November 8, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

benzinga.com
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 369 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 275 companies made new 52-week lows.

benzinga.com
Earnings Scheduled For August 9, 2023

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

benzinga.com
Earnings Scheduled For May 10, 2023

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

benzinga.com
Earnings Scheduled For March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly

benzinga.com
Earnings Scheduled For November 9, 2022

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

benzinga.com
Earnings Scheduled For August 10, 2022

  Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for i

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 951 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 1214 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 422 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.